Published in Mol Cancer Res on November 16, 2012
CXC chemokines and chemokine receptors in gastric cancer: from basic findings towards therapeutic targeting. World J Gastroenterol (2014) 1.02
HDM2 regulation by AURKA promotes cell survival in gastric cancer. Clin Cancer Res (2013) 0.94
Gastric tumour-derived ANGPT2 regulation by DARPP-32 promotes angiogenesis. Gut (2015) 0.81
Regulation of CD44E by DARPP-32-dependent activation of SRp20 splicing factor in gastric tumorigenesis. Oncogene (2015) 0.81
Prognostic value of a 92-probe signature in breast cancer. Oncotarget (2015) 0.81
DARPP-32: from neurotransmission to cancer. Oncotarget (2016) 0.75
A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res (2001) 124.61
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer (2010) 90.16
Metastasis suppressors alter the signal transduction of cancer cells. Nat Rev Cancer (2003) 3.96
Membrane type 1 matrix metalloproteinase digests interstitial collagens and other extracellular matrix macromolecules. J Biol Chem (1997) 3.74
The role of CXCR7/RDC1 as a chemokine receptor for CXCL12/SDF-1 in prostate cancer. J Biol Chem (2007) 3.38
The E3 ubiquitin ligase AIP4 mediates ubiquitination and sorting of the G protein-coupled receptor CXCR4. Dev Cell (2003) 2.97
Gastric cancer. Crit Rev Oncol Hematol (2009) 2.87
Agonist-promoted ubiquitination of the G protein-coupled receptor CXCR4 mediates lysosomal sorting. J Biol Chem (2001) 2.72
Metastasis mechanisms. Biochim Biophys Acta (2009) 2.51
Membrane-type 1 matrix metalloproteinase: a key enzyme for tumor invasion. Cancer Lett (2003) 2.46
The chemokine and chemokine receptor superfamilies and their molecular evolution. Genome Biol (2006) 2.42
A large-scale study of MT1-MMP as a marker for isolated tumor cells in peripheral blood and bone marrow in gastric cancer cases. Ann Surg Oncol (2008) 2.32
Matrix metalloproteinase proteomics: substrates, targets, and therapy. Curr Opin Cell Biol (2009) 1.65
Breast cancer lung metastasis requires expression of chemokine receptor CCR4 and regulatory T cells. Cancer Res (2009) 1.64
Activation of Vav/Rho GTPase signaling by CXCL12 controls membrane-type matrix metalloproteinase-dependent melanoma cell invasion. Cancer Res (2006) 1.49
Expression and tissue localization of membrane-type 1, 2, and 3 matrix metalloproteinases in human astrocytic tumors. Am J Pathol (1999) 1.42
Mechanisms of metastasis. Breast Cancer Res (2008) 1.34
Gastric cancers overexpress DARPP-32 and a novel isoform, t-DARPP. Cancer Res (2002) 1.33
HER2 interacts with CD44 to up-regulate CXCR4 via epigenetic silencing of microRNA-139 in gastric cancer cells. Gastroenterology (2011) 1.22
Darpp-32: a novel antiapoptotic gene in upper gastrointestinal carcinomas. Cancer Res (2005) 1.19
The chemokine receptor CXCR4 and the metalloproteinase MT1-MMP are mutually required during melanoma metastasis to lungs. Am J Pathol (2009) 1.17
Analysis of MT1-MMP and MMP2 expression in human gastric cancers. Int J Cancer (1997) 1.12
Chemokine receptor CXCR4 expression, function, and clinical implications in gastric cancer. Int J Oncol (2009) 1.10
YK-4-279 inhibits ERG and ETV1 mediated prostate cancer cell invasion. PLoS One (2011) 1.07
Overexpression of the 32-kilodalton dopamine and cyclic adenosine 3',5'-monophosphate-regulated phosphoprotein in common adenocarcinomas. Cancer (2003) 1.06
DARPP-32 and phosphatase inhibitor-1, two structurally related inhibitors of protein phosphatase-1, are both present in striatonigral neurons. J Neurochem (1988) 0.99
The expression of CXCL12 and CXCR4 in gastric cancer and their correlation to lymph node metastasis. Med Oncol (2011) 0.96
Dopamine and cAMP regulated phosphoprotein MW 32 kDa is overexpressed in early stages of gastric tumorigenesis. Surgery (2010) 0.94
A novel in vitro assay system for transendothelial tumor cell invasion: significance of E-selectin and alpha 3 integrin in the transendothelial invasion by HT1080 fibrosarcoma cells. Clin Exp Metastasis (1994) 0.94
DARPP-32 increases interactions between epidermal growth factor receptor and ERBB3 to promote tumor resistance to gefitinib. Gastroenterology (2011) 0.91
The role of N-glycosylation sites on the CXCR4 receptor for CXCL-12 binding and signaling and X4 HIV-1 viral infectivity. Virology (2007) 0.90
Predictive factors for lymph node metastasis in early gastric cancer. World J Gastroenterol (2010) 0.87
Overexpression of DARPP-32 in colorectal adenocarcinoma. Int J Clin Pract (2005) 0.84
Early gastric cancer with widespread duodenal invasion within the mucosa. Dig Endosc (2010) 0.78
NLRC5 negatively regulates the NF-kappaB and type I interferon signaling pathways. Cell (2010) 2.49
NLRX1 negatively regulates TLR-induced NF-κB signaling by targeting TRAF6 and IKK. Immunity (2011) 2.10
Aurora kinase inhibitors--rising stars in cancer therapeutics? Mol Cancer Ther (2010) 1.91
Epigenetic silencing of somatostatin in gastric cancer. Dig Dis Sci (2010) 1.61
The TWIST/Mi2/NuRD protein complex and its essential role in cancer metastasis. Cell Res (2010) 1.56
Regulation of p53 tumor suppressor by Helicobacter pylori in gastric epithelial cells. Gastroenterology (2010) 1.45
Aurora kinase A inhibition leads to p73-dependent apoptosis in p53-deficient cancer cells. Cancer Res (2008) 1.37
The aurora kinase A inhibitor MLN8237 enhances cisplatin-induced cell death in esophageal adenocarcinoma cells. Mol Cancer Ther (2012) 1.33
Interaction of Helicobacter pylori with gastric epithelial cells is mediated by the p53 protein family. Gastroenterology (2008) 1.33
Frequent overexpression of Aurora Kinase A in upper gastrointestinal adenocarcinomas correlates with potent antiapoptotic functions. Cancer (2008) 1.32
Therapeutic prospects for p73 and p63: rising from the shadow of p53. Drug Resist Updat (2008) 1.32
Yeast TFIID serves as a coactivator for Rap1p by direct protein-protein interaction. Mol Cell Biol (2006) 1.31
Overexpression of OATP1B3 confers apoptotic resistance in colon cancer. Cancer Res (2008) 1.20
Promoter DNA hypermethylation in gastric biopsies from subjects at high and low risk for gastric cancer. Int J Cancer (2010) 1.18
Regulation of cell-cell interactions by phosphatidic acid phosphatase 2b/VCIP. EMBO J (2003) 1.17
t-Darpp promotes cancer cell survival by up-regulation of Bcl2 through Akt-dependent mechanism. Cancer Res (2008) 1.15
Loss of TFF1 is associated with activation of NF-κB-mediated inflammation and gastric neoplasia in mice and humans. J Clin Invest (2011) 1.15
TFIIA and the transactivator Rap1 cooperate to commit TFIID for transcription initiation. Nature (2010) 1.12
Pathogenic bacterium Helicobacter pylori alters the expression profile of p53 protein isoforms and p53 response to cellular stresses. Proc Natl Acad Sci U S A (2012) 1.11
Glutathione peroxidase 7 protects against oxidative DNA damage in oesophageal cells. Gut (2011) 1.08
Aurora kinase A promotes inflammation and tumorigenesis in mice and human gastric neoplasia. Gastroenterology (2013) 1.07
Deciphering the unique microRNA signature in human esophageal adenocarcinoma. PLoS One (2013) 1.05
Silencing of glutathione peroxidase 3 through DNA hypermethylation is associated with lymph node metastasis in gastric carcinomas. PLoS One (2012) 1.02
Expression of t-DARPP mediates trastuzumab resistance in breast cancer cells. Clin Cancer Res (2008) 1.02
Early involvement of death-associated protein kinase promoter hypermethylation in the carcinogenesis of Barrett's esophageal adenocarcinoma and its association with clinical progression. Neoplasia (2007) 1.01
Neuroprotective efficacy from a lipophilic redox-modulating Mn(III) N-Hexylpyridylporphyrin, MnTnHex-2-PyP: rodent models of ischemic stroke and subarachnoid hemorrhage. J Pharmacol Exp Ther (2011) 1.01
Mapping the initiator binding Taf2 subunit in the structure of hydrated yeast TFIID. Structure (2009) 1.01
BVES regulates EMT in human corneal and colon cancer cells and is silenced via promoter methylation in human colorectal carcinoma. J Clin Invest (2011) 1.00
Profiling bladder cancer organ site-specific metastasis identifies LAMC2 as a novel biomarker of hematogenous dissemination. Am J Pathol (2009) 1.00
Isolation, transposon mutagenesis, and characterization of the novel nicotine-degrading strain Shinella sp. HZN7. Appl Microbiol Biotechnol (2013) 0.99
ABL regulation by AXL promotes cisplatin resistance in esophageal cancer. Cancer Res (2012) 0.98
Molecular dissection of 17q12 amplicon in upper gastrointestinal adenocarcinomas. Mol Cancer Res (2006) 0.97
p73 protein regulates DNA damage repair. FASEB J (2011) 0.96
Lmo2 induces hematopoietic stem cell-like features in T-cell progenitor cells prior to leukemia. Stem Cells (2013) 0.96
p73 isoforms can induce T-cell factor-dependent transcription in gastrointestinal cells. Cancer Res (2004) 0.96
Expression of calcium-binding proteins S100A2 and S100A4 in Barrett's adenocarcinomas. Neoplasia (2006) 0.95
Gastric adenocarcinoma has a unique microRNA signature not present in esophageal adenocarcinoma. Cancer (2013) 0.95
Dopamine and cAMP regulated phosphoprotein MW 32 kDa is overexpressed in early stages of gastric tumorigenesis. Surgery (2010) 0.94
HDM2 regulation by AURKA promotes cell survival in gastric cancer. Clin Cancer Res (2013) 0.94
Cell cycle-dependent regulation of the bi-directional overlapping promoter of human BRCA2/ZAR2 genes in breast cancer cells. Mol Cancer (2010) 0.93
Methylation-dependent activation of CDX1 through NF-κB: a link from inflammation to intestinal metaplasia in the human stomach. Am J Pathol (2012) 0.91
DARPP-32 increases interactions between epidermal growth factor receptor and ERBB3 to promote tumor resistance to gefitinib. Gastroenterology (2011) 0.91
Location-specific epigenetic regulation of the metallothionein 3 gene in esophageal adenocarcinomas. PLoS One (2011) 0.91
t-DARPP regulates phosphatidylinositol-3-kinase-dependent cell growth in breast cancer. Mol Cancer (2010) 0.90
Proinflammatory cytokines and bile acids upregulate ΔNp73 protein, an inhibitor of p53 and p73 tumor suppressors. PLoS One (2013) 0.90
Regulation of β-catenin by t-DARPP in upper gastrointestinal cancer cells. Mol Cancer (2011) 0.89
Nestin expression in end-stage disease in dystrophin-deficient heart: implications for regeneration from endogenous cardiac stem cells. Stem Cells Transl Med (2013) 0.89
Epigenetic and genetic silencing of CHFR in esophageal adenocarcinomas. Cancer (2010) 0.88
Down-regulation of 7SL RNA expression and impairment of vesicular protein transport pathways by Leishmania infection of macrophages. J Biol Chem (2005) 0.88
Transcriptional oncogenomic hot spots in Barrett's adenocarcinomas: serial analysis of gene expression. Genes Chromosomes Cancer (2007) 0.88
Cell-permeable NM23 blocks the maintenance and progression of established pulmonary metastasis. Cancer Res (2011) 0.88
Alterations in Barrett's-related adenocarcinomas: a proteomic approach. Int J Cancer (2008) 0.88
Role of proinflammatory cytokines (interferon gamma) and anti-inflammatory cytokine (interleukin-10) gene polymorphisms in chronic hepatitis B infection: an Indian scenario. J Interferon Cytokine Res (2014) 0.88
Regulation of ERBB2 receptor by t-DARPP mediates trastuzumab resistance in human esophageal adenocarcinoma. Cancer Res (2012) 0.87
Size-dependent properties of M-PEIs nanogels for gene delivery in cancer cells. Int J Pharm (2007) 0.87
Esophageal adenocarcinoma: treatment modalities in the era of targeted therapy. Dig Dis Sci (2010) 0.85
Protein translocase of mitochondrial inner membrane in Trypanosoma brucei. J Biol Chem (2012) 0.85
Resistance to TRAIL is mediated by DARPP-32 in gastric cancer. Clin Cancer Res (2012) 0.84
Effect of copper on the degradation of pesticides cypermethrin and cyhalothrin. J Environ Sci (China) (2007) 0.84
The effect of intracellular protein delivery on the anti-tumor activity of recombinant human endostatin. Biomaterials (2013) 0.83
Psychological consequences derived during process of human hand allograft. Chin Med J (Engl) (2002) 0.82
Antitumor activity of cell-permeable RUNX3 protein in gastric cancer cells. Clin Cancer Res (2012) 0.82
Antitumor activity of cell-permeable p18(INK4c) with enhanced membrane and tissue penetration. Mol Ther (2012) 0.81
AXL mediates TRAIL resistance in esophageal adenocarcinoma. Neoplasia (2013) 0.80
Reduction of 8-iso-prostaglandin F2α in the first week after Roux-en-Y gastric bypass surgery. Obesity (Silver Spring) (2011) 0.79
Methylation of promoters of microRNAs and their host genes in myelodysplastic syndromes. Leuk Lymphoma (2013) 0.79
Functional PstI/RsaI polymorphism in CYP2E1 is associated with the development, progression and poor outcome of gastric cancer. PLoS One (2012) 0.78
Biochanin A reduces pancreatic cancer survival and progression. Anticancer Drugs (2014) 0.78
Global transcriptional profiling in porcine mammary glands from late pregnancy to peak lactation. OMICS (2012) 0.78
Dual behavior of sodium dodecyl sulfate as enhancer or suppressor of insulin aggregation and chaperone-like activity of camel alphaS(1)-casein. Int J Biol Macromol (2009) 0.78
Low-temperature preparation and microwave photocatalytic activity study of TiO2-mounted activated carbon. J Hazard Mater (2006) 0.78
Assessing interactions between common genetic variant on 2q35 and hormone receptor status with breast cancer risk: evidence based on 26 studies. PLoS One (2013) 0.77
Facile hydrothermal synthesis of nanostructured hollow iron-cerium alkoxides and their superior arsenic adsorption performance. ACS Appl Mater Interfaces (2014) 0.77
A type II ribonuclease H from Leishmania mitochondria: an enzyme essential for the growth of the parasite. Mol Biochem Parasitol (2005) 0.76
ApoE mimetic ameliorates motor deficit and tissue damage in rat spinal cord injury. J Neurosci Res (2014) 0.76
5-Methylcytosine hydroxylation-mediated LINE-1 hypomethylation: a novel mechanism of proto-oncogenes activation in colorectal cancer? Gut (2013) 0.76
Implication of disulfide bridge induced thermal reversibility, structural and functional stability for luciferase. Protein Pept Lett (2015) 0.76
Preparation and characterization of amino-functionalized magnetic nanogels via photopolymerization for MRI applications. Colloids Surf B Biointerfaces (2009) 0.76